Table 3 Overall clinical outcomes
Treatment and outcome | All patients (n = 26) |
|---|---|
Occurrence of ESRD, no. (%) | 7 (27) |
Mortality, no. (%) | 2 (8) |
Renal survival, no. (%) | 19 (73) |
Stable disease, no. (%) | 12 (46) |
Progressive disease, no. (%) | 5 (19) |
Complete remission, no. (%) | 6 (23) |
Treatment and outcome, no. (%) | |
ACE inhibitor | 16 (62%) |
Prednisone only | 3 (12) |
Prednisone and MMF | 12 (46) |
Other immunosuppression | 5 (19) |
Not treated | 6 (23) |